The Global Polio Eradication Strategy 2022-2026 supersedes the Polio Strategy 2019-2023, taking into account new tools and approaches, including the novel oral polio vaccine type 2 and need to more concertedly address vaccine-derived polioviruses, as well as new operations tactics in light of the ongoing COVID-19 pandemic. It is intended to layout the roadmap to achieving and sustaining a polio-free world, free of all forms of poliovirus. It is intended to be a strategic resource and guidance document for GPEI stakeholders, partners, donors and affected country governments.

The Global Polio Eradication Strategy 2022-2026 supersedes the Polio Strategy 2019-2023, taking into account new tools and approaches, including the novel oral polio vaccine type 2 and need to more concertedly address vaccine-derived polioviruses, as well as new operations tactics in light of the ongoing COVID-19 pandemic. It is intended to layout the roadmap to achieving and sustaining a polio-free world, free of all forms of poliovirus. It is intended to be a strategic resource and guidance document for GPEI stakeholders, partners, donors and affected country governments.

This is a significant revision of the existing Standard Operating Procedures necessitated by recent advances in outbreak response, principally the Emergency Use Listing of novel oral polio vaccine type 2 in 2021. This is the fourth version of the polio outbreak SOPs which give response teams in countries step by step guidance on how to respond, including vaccine choice and scope of the response in countries, and how these steps are supported by the Global Polio Eradication Initiative (GPEI).